Adenylyl cyclase isoforms as novel therapeutic targets: An exciting example of excitotoxicity neuroprotection

Molecular Interventions

Volumn 7, Issue 2, 2007, Pages 70-73

  Watts, Val J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; ADENYLYL CYCLASE TYPE 1; ADENYLYL CYCLASE TYPE 2; ADENYLYL CYCLASE TYPE 3; ADENYLYL CYCLASE TYPE 4; ADENYLYL CYCLASE TYPE 5; ADENYLYL CYCLASE TYPE 6; ADENYLYL CYCLASE TYPE 7; ADENYLYL CYCLASE TYPE 8; ADENYLYL CYCLASE TYPE 9; CALMIDAZOLIUM; CALMODULIN; CATECHOL ESTROGEN; CYCLIC AMP; FORSKOLIN; GLUTAMATE SODIUM; ISOENZYME; ISOPROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE C; TYRPHOSTIN A25; UNCLASSIFIED DRUG;

BRAIN CELL; CALCIUM SIGNALING; DRUG BINDING; DRUG BINDING SITE; DRUG TARGETING; ENZYME ACTIVATION; EXCITOTOXICITY; GENE DELETION; LONG TERM MEMORY; LONG TERM POTENTIATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SITE DIRECTED MUTAGENESIS;

ADENYLATE CYCLASE; ANIMALS; HUMANS; ISOENZYMES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 34247626753     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.7.2.6     Document Type: Review

References (38)

1. Wang, H., Gong, B., Vadakkan, K.I., Toyoda, H., Kaang, B.K., and Zhuo, M. Genetic evidence for adenylyl cyclase 1 as a target for preventing neuronal excitotoxicity mediated by N-methyl-D-aspartate receptors. J. Biol. Chem. 282, 1507-1517 (2007). This study forms the basis for the current viewpoint and suggests that AC1 is involved in excitotoxicity.
2. Fan, M.M. and Raymond, L.A. N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. doi:10.1016/j.pneurobio.2006.11.003 (2006).
3. Arundine, M. and Tymianski, M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668 (2004).
4. Hanoune, J. and Defer, N. Regulation and role of adenylyl cyclase isoforms. Ann. Rev. Pharmacol. Toxicol. 41, 145-174 (2001).
5. Krupinski, J., Coussen, F., Bakalyar, H.A., Tang, W.J., Feinstein, P.G., Orth, K., Slaughter, C., Reed, R.R., and Gilman, A.G. Adenylyl cyclase amino acid sequence: Possible channel- or transporter-like structure. Science 244, 1558-1564 (1989).
6. Buck, J., Sinclair, M.L., Schapal, L., Cann, M.J., and Levin, L.R. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc. Natl. Acad. Sci. U.S.A. 96, 79-84 (1999).
7. Beazely, M.A. and Watts, V.J. Regulatory properties of adenylate cyclases type 5 and 6: A progress report. Eur. J. Pharmacol. 535, 1-12 (2006).
8. Sunahara, R.K. and Taussig, R. Isoforms of mammalian adenylyl cyclase: Multiplicities of signaling. Mol. Interv. 2, 168-184 (2002).
9. Ostrom, R.S., Liu, X., Head, B.P., Gregorian, C., Seasholtz, T.M., and Insel, P.A. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: Expression in caveolin-rich and noncaveolin domains. Mol. Pharmacol. 62, 983-992 (2002).
10. Cooper, D.M. and Crossthwaite, A.J. Higher-order organization and regulation of adenylyl cyclases. Trends Pharmacol. Sci. 27, 426-431 (2006).
11. Defer, N., Best-Belpomme, M., and Hanoune, J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am. J. Physiol. Renal Physiol. 279, F400-F416 (2000).
12. Lane-Ladd, S.B., Pineda, J., Boundy, V.A., Pfeuffer, T., Krupinski, J., Aghajanian, G.K., and Nestler, E.J. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890-7901 (1997).
13. Chern, Y. Regulation of adenylyl cyclases in the central nervous system. Cell. Signal. 12, 195-204 (2000).
14. Conti, A.C., Maas, J.W., Jr., Muglia, L.M., Dave, B.A., Vogt, S.K., Tran, T.T., Rayhel, E.J., and Muglia, L.J. Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience doi:10.1016/j.neuroscience.2007.01.045 (2007).
15. Johnston, C.A., Beazely, M.A., Bilodeau, M.L., Andrisani, O., and Watts, V.J. Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line. J. Neurochem. 88, 1497-1508 (2004).
16. s independent. Neuropharmacology doi:10.1016/j.neuropharm.2005.11.004 (2005).
17. -/- , and double knock-out (DKO) animals.
18. Wong, S.T., Athos, J., Figueroa, X.A., Pineda, V.V., Scheafer, M.L., Chavkin, C.C., Muglia, L.J., and Storm, D.R. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 23, 787-798 (1999). This report represents the first study using a transgenic mouse model where the genes for both AC1 and AC8 were disrupted (DKO animals) to examine memory and LTP.
19. 2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931-7940 (2002).
20. Tang, W.J. and Gilman, A.G. Type-specific regulation of adenylyl cyclase by G protein α subunits. Science 254, 1500-1502 (1991).
21. Choi, E.J., Wong, W.T., Hinds, T.R., and Storm, D.R. Calcium and muscarinic agonist stimulation of type I adenylyl cyclase in whole cells. J. Biol. Chem. 267, 12440-12442 (1992).
22. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J. Biol. Chem. 269, 12190-12195 (1994).
23. Chetkovich, D.M. and Sweatt, J.D. NMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J. Neurochem. 61, 1933-1942 (1993).
24. 2+-stimulated adenylyl cyclases in behavioral responses to inflammatory stimuli.
25. 2+ in HEK293 cells.
26. Lonze, B.E. and Ginty, D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623 (2002).
27. Lee, B., Butcher, G.Q., Hoyt, K.R., Impey, S., and Obrietan, K. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J. Neurosci. 25, 1137-1148 (2005).
28. Maas, J.W., Jr., Indacochea, R.A., Muglia, L.M. et al. Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain. J. Neurosci. 25, 2376-2385 (2005). This study reveals a similar level of excitotoxicity in wild type and DKO mice following administration of monosodium glutamate.
29. Dessauer, C.W., Tesmer, J.J., Sprang, S.R., and Gilman, A.G. The interactions of adenylate cyclases with P-site inhibitors. Trends Pharmacol. Sci. 20, 205-210 (1999).
30. Johnson, R.A., Desaubry, L., Bianchi, G. et al. Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3′-polyphosphates. J. Biol. Chem. 272, 8962-8966 (1997).
31. Onda, T., Hashimoto, Y., Nagai, M. et al. Type-specific regulation of adenylyl cyclase. J. Biol. Chem. 276, 47785-47793 (2001).
32. Haunso, A., Simpson, J., and Antoni, F.A. Small ligands modulating the activity of mammalian adenylyl cyclases: A novel mode of inhibition by calmidazolium. Mol. Pharmacol. 63, 624-631 (2003).
33. Steegborn, C., Litvin, T.N., Hess, K.C., Capper, A.B., Taussig, R., Buck, J., Levin, L.R., and Wu, H. A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen. J. Biol. Chem. 280, 31754-31759 (2005).
34. Jaleel, M., Shenoy, A.R., and Visweswariah, S.S. Tyrphostins are inhibitors of guanylyl and adenylyl cyclases. Biochemistry 43, 8247-8255 (2004).
35. Sastry, A., Arnold, E., Gurji, H. et al. Cardiac-directed expression of adenylyl cyclase VI facilitates atrioventricular nodal conduction. J. Am. Coll. Cardiol. 48, 559-565 (2006).
36. Donohue, T., Hoffman, P.L., and Tabakoff, B. Effect of ethanol on DARPP-32 phosphorylation in transgenic mice that express human type VII adenylyl cyclase in brain. Alcohol Clin. Exp. Res. 29, 310-316 (2005).
37. Wang, H., Ferguson, G.D., Pineda, V.V., Cundiff, P.E., and Storm, D.R. Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat. Neurosci. 7, 635-642 (2004).
38. Lazo, J.S. Roadmap or roadkill: A pharmacologist's analysis of the NIH Molecular Libraries Initiative. Mol. Interv. 6, 240-243 (2006). This short article discusses a recent NIH initiative for academic scientists to identify small molecule probes for novel targets.